medigraphic.com

2004, Number s2

<< Back Next >>

Arch Cardiol Mex 2004; 74 (s2)

Dilated cardiomyopathy. The state of the art.

Méndez OA

Language: Spanish
References: 11
Page: 338-342
PDF size: 50.39 Kb.


ABSTRACT

Dilated myocardiopathy is included in the group of unknown cause diseases. Its morphological characterization consists in dilating the four cardiac cavities, giving place to cardiac failure. Recently, a relationship between inflammatory state, apoptosis, and certain infections conditions from viral origin has been established. This has allowed designing therapeutic strategies with immunomodulatory drugs and steam cells transplantation.


REFERENCES

  1. Edwars W, Holmes D: Cardiomyopathy and biopsy. En: Guiliani E: Mayo Clinic Practice of Cardiology. 3° Ed. St. Louis, MO. Mosby. 1996, p.672-88.

  2. Nadal-Ginard B, Kajstura J, Anversa P, Leri A: A matter of life and death: cardiac myocyte apoptosis and regeneration. J Clin Invest 2003; 111: 1457-9.

  3. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor S, et al: A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003; 111: 1497-504.

  4. Cooper L, Gersh B: Viral infection, inflammation, and the risk of idiopathic Dilated Cardiomyopathy: Can the fire be extinguished. Am J Cardiol 2002; 90: 751-4.

  5. Ku L, Feiger J, Taylor M, Mestroni L: Familial Dilated Cardiomyopathy. Circulation 2003; 108: e118-e121.

  6. Michels V, Driscoll D, Miller F, Olson T, Atkinson Eoswold C, et al: Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart 2003; 89: 757-61.

  7. Donahue M, Kraus W, Granger C: Genetics in heart failure: practical incorporation of this new biologic dimension. Am Heart J 2002; 144: 938-40.

  8. Bertoni A, Kasper E, Tsai A, Brancati F: Diabetes and idiopathic cardiomyopathy. A nationwide case-control study. Diabetes Care 2003; 26: 2791-95.

  9. Brooks A, Schinde V, Bateman A, Gallagher P: Interstitial fibrosis in the dilated non-ischemic myocardium. Heart 2003; 89: 1255-6.

  10. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J: Possible cause of taurine-deficient cardiomyopathy: Potentiation of angiotensin II action. J Cardiovasc Pharmacol 2003; 41: 751-9.

  11. Staudt A, Bôhm M, Knebel F, Grosse Y, Bischoff C, Hummel A, et al: Potential role of autoantibodies belonging to the inmunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2848-53.




2020     |     www.medigraphic.com